Among the positive regulators that C-search and conventional log-rank analysis found, two genes are found in common in both algorithms: KRAS and PRKACG. The KRAS gene targets several miRNAs to enhance chemotherapy in acute myeloid leukemia, lung cancer, breast cancer, and gallbladder cancer [34–36]. This evidence concerns the gene KRAS and lung cancer.